Cite
HARVARD Citation
Tawbi, H. et al. (n.d.). Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet oncology. 18 (11), pp. 1493-1501. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tawbi, H. et al. (n.d.). Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet oncology. 18 (11), pp. 1493-1501. [Online].